Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II randomized double-blind placebo-controlled study of DA-302168S tablets in overweight or obese adults
CTR20251116Phase 2Completed
- Sponsor
- Chengdu Di'ao Pharmaceutical Group
- Start
- May 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of DA-302168S in obesity, Overweight, sponsored by Chengdu Di'ao Pharmaceutical Group. Started May 2025; status: completed.
02
Drugs
DA-302168S
03
Conditions
obesityOverweight
Beyond the preview
Go deeper on CTR20251116.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20251116.